Pharma space just delivered another market star, stunning investors with breakout growth.
Written By
RAJ ANAND
IMAGE CREDIT
While most sectors treaded cautiously, this company posted blockbuster quarterly profits.
Written By
RAJ ANAND
IMAGE CREDIT
Net profit surged sharply compared to last year, signaling solid business momentum.
Written By
RAJ ANAND
IMAGE CREDIT
Markets reacted instantly — stock spiked nearly 15% to a fresh yearly high.
Written By
RAJ ANAND
IMAGE CREDIT
The multibagger has already delivered 190%+ gains in one year, rewarding patient holders.
Written By
RAJ ANAND
IMAGE CREDIT
Revenue grew steadily, supported by expansion in global markets and niche formulations.
Written By
RAJ ANAND
IMAGE CREDIT
Margins jumped meaningfully, showcasing improved pricing, scale, and operational execution.
Written By
RAJ ANAND
IMAGE CREDIT
US business stayed strong, with management confident of touching $400M in future revenue.
Written By
RAJ ANAND
IMAGE CREDIT
Europe also remains key, with new partners and pipeline launches boosting long-term visibility.
Written By
RAJ ANAND
IMAGE CREDIT
That star stock? Strides Pharma — quietly building global in branded and generic drugs.
Written By
RAJ ANAND
IMAGE CREDIT
This Secret Mobility Stock Doubles After IPO.